Form 8-K - Current report:
SEC Accession No. 0001437749-25-020669
Filing Date
2025-06-17
Accepted
2025-06-17 16:31:02
Documents
13
Period of Report
2025-06-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clnn20250617_8k.htm   iXBRL 8-K 26988
  Complete submission text file 0001437749-25-020669.txt   177010

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA clnn-20250617.xsd EX-101.SCH 4123
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20250617_def.xml EX-101.DEF 13919
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20250617_lab.xml EX-101.LAB 18404
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20250617_pre.xml EX-101.PRE 13951
15 EXTRACTED XBRL INSTANCE DOCUMENT clnn20250617_8k_htm.xml XML 5097
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 251053756
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)